Cambridge Healthtech Institute’s 13th Annual

Liquid Biopsy

Enabling Precision Oncology for Diagnostic and Drug Development

MARCH 6 - 7, 2023 ALL TIMES PST

Liquid biopsy is a maturing technology for early detection of disease, patient stratification and therapy selection, monitoring response to therapy, and detecting disease recurrence. Cambridge Healthtech Institute’s 13th Annual Liquid Biopsy meeting will explore the latest technologies in detection and molecular characterization of CTCs, cell-free circulating tumor DNA (cfDNA) and circulating extracellular RNA, exosomes and microvesicles, as well as the applications of liquid biopsy in diagnostics and drug development.